Stock listing

MOB Stock Price, News, Filings & Events — Moberg Pharma Ab

Selected listing: MOB · OMXSTO · SEK · SE

This page tracks Moberg Pharma Ab's MOB:OMXSTO listing on OMXSTO in SEK for SE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MOB:OMXSTO. MOB:OMXSTO is the stock-level entry point for investors researching Moberg Pharma Ab, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Moberg Pharma Ab is a public company listed on the Swedish market under the ticker MOB. The company has a market capitalization of approximately 45.97 million USD. Moberg Pharma focuses on developing and commercializing innovative pharmaceutical products.

MOB:OMXSTOSEKSEUpdated September 12, 2026
Moberg Pharma Ab logo
Ticker
MOB:OMXSTO
Asset type
Stock
Market cap
$53.6M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
OMXSTO
Currency
SEK

Moberg Pharma Ab MOB:OMXSTO stock context

This page tracks Moberg Pharma Ab's MOB:OMXSTO listing on OMXSTO in SEK for SE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MOB:OMXSTO. MOB:OMXSTO is the stock-level entry point for investors researching Moberg Pharma Ab, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Moberg Pharma Ab is a public company listed on the Swedish market under the ticker MOB. The company has a market capitalization of approximately 45.97 million USD. Moberg Pharma focuses on developing and commercializing innovative pharmaceutical products.

Latest news from Moberg Pharma Ab

All Moberg Pharma Ab news →

Moberg Pharma Ab earnings calls

Research Moberg Pharma Ab

Alternate listings